Comparison of clinical state, retrospective informant interview and the neuropathologic diagnosis of alzheimer's disease

Publisher Website
Google Scholar
Abstract
This study compared clinical diagnosis of dementia derived from medical records and a retrospective version of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) against the criterion of neuropathology. Subjects comprised 50 consecutive patients who died in a geriatric hospital in Melbourne and underwent necropsy. All informants were seen within 3.5 years of death. Discordance between clinical and pathological diagnosis occurred in seven (14%) cases. The IQCODE scores for the group with a clinical diagnosis of Alzheimer's disease (mean ± SD) were 4.28 ± 0.78 and were significantly different from the non‐demented group, 3.39 ± 0.51, p < 0.001. Similarly, IQCODE scores were significantly different between the groups with and without a pathologic diagnosis of Alzheimer's disease, 4.21 ± 0.70 and 3.51 ± 0.79 respectively, p < 0.01. Using immunohistochemical techniques instead of conventional methods to make a diagnosis of Alzheimer's disease, there were significant differences in IQCODE scores between the Alzheimer's group, 4.13 ± 0.83, and the group with normal neuropathology, 3.45 ± 0.54, p < 0.01. These data support the conclusion that when used retrospectively, the IQCODE is a valid screening test for dementia using neuropathological diagnosis as the criterion.